iBio Inc. [AMEX: IBIO] jumped around 0.01 points on Wednesday, while shares priced at $1.56 at the close of the session, up 0.65%. iBio Inc. stock is now 526.51% up from its year-to-date (YTD) trading value. IBIO Stock saw the intraday high of $1.57 and lowest of $1.48 per share. The company’s 52-week high price is 3.40, which means current price is +642.86% above from all time high which was touched on 02/28/20.
Compared to the average trading volume of 12.42M shares, IBIO reached a trading volume of 3892491 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about iBio Inc. [IBIO]?
The Average True Range (ATR) for iBio Inc. is set at 0.17, with the Price to Sales ratio for IBIO stock in the period of the last 12 months amounting to 126.65. The Price to Book ratio for the last quarter was 31.20, with the Price to Cash per share for the same quarter was set at 0.09.
How has IBIO stock performed recently?
iBio Inc. [IBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.65. With this latest performance, IBIO shares dropped by -10.86% in over the last four-week period, additionally plugging by 704.12% over the last 6 months – not to mention a rise of 92.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IBIO stock in for the last two-week period is set at 55.83, with the RSI for the last a single of trading hit 53.87, and the three-weeks RSI is set at 55.48 for iBio Inc. [IBIO]. The present Moving Average for the last 50 days of trading for this stock 1.2521, while it was recorded at 1.5280 for the last single week of trading, and 0.7182 for the last 200 days.
iBio Inc. [IBIO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and iBio Inc. [IBIO] shares currently have an operating margin of -773.49. iBio Inc.’s Net Margin is presently recorded at -871.80.
Return on Total Capital for IBIO is now -45.52, given the latest momentum, and Return on Invested Capital for the company is -51.60. Return on Equity for this stock declined to -188.88, with Return on Assets sitting at -47.76. When it comes to the capital structure of this company, iBio Inc. [IBIO] has a Total Debt to Total Equity ratio set at 1,010.31. Additionally, IBIO Total Debt to Total Capital is recorded at 90.99, with Total Debt to Total Assets ending up at 81.36. Long-Term Debt to Equity for the company is recorded at 1,001.66, with the Long-Term Debt to Total Capital now at 90.21.
Reflecting on the efficiency of the workforce at the company, iBio Inc. [IBIO] managed to generate an average of -$2,932,167 per employee. Receivables Turnover for the company is 23.47 with a Total Asset Turnover recorded at a value of 0.05.iBio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 1.70.
Insider trade positions for iBio Inc. [IBIO]
There are presently around $5 million, or 11.20% of IBIO stock, in the hands of institutional investors. The top three institutional holders of IBIO stocks are: VANGUARD GROUP INC with ownership of 948,821, which is approximately 778.343% of the company’s market cap and around 1.20% of the total institutional ownership; BLACKROCK INC., holding 823,190 shares of the stock with an approximate value of $1.28 million in IBIO stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.5 million in IBIO stock with ownership of nearly 847.881% of the company’s market capitalization.
Positions in iBio Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 32 institutional holders increased their position in iBio Inc. [AMEX:IBIO] by around 2,230,351 shares. Additionally, 6 investors decreased positions by around 300,528 shares, while 1 investors held positions by with 657,236 shares. The mentioned changes placed institutional holdings at 3,188,115 shares, according to the latest SEC report filing. IBIO stock had 23 new institutional investments in for a total of 856,536 shares, while 4 institutional investors sold positions of 192,362 shares during the same period.